Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 34 (RPL7AP34) is a processed pseudogene of the RPL7A gene, which encodes the ribosomal protein L7a. As a pseudogene, RPL7AP34 does not produce a functional protein and is not involved in known biological pathways or drug responses. It is listed in genomic databases as a non-coding, non-functional sequence that resembles RPL7A but lacks evidence of transcription or translation into a functional protein product. Pseudogenes such as RPL7AP34 are typically regarded as remnants of gene duplication events and are not considered therapeutic targets.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 34 (RPL7AP34).